ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO064

Geographic Disparities in the Rate of Major Adverse Kidney Events Among Patients with CKD in Alberta

Session Information

Category: Diversity and Equity in Kidney Health

  • 900 Diversity and Equity in Kidney Health

Authors

  • Lunyera, Joseph, University of Alberta, Edmonton, Alberta, Canada
  • Ye, Feng, University of Alberta, Edmonton, Alberta, Canada
  • Thompson, Stephanie E., University of Alberta, Edmonton, Alberta, Canada
  • Jindal, Kailash K., University of Alberta, Edmonton, Alberta, Canada
  • Klarenbach, Scott, University of Alberta, Edmonton, Alberta, Canada
  • Bello, Aminu K., University of Alberta, Edmonton, Alberta, Canada
Background

Individuals in rural communities in Alberta disproportionately experience adverse health outcomes. Characterizing temporal trends in the incidence of major adverse kidney events (MAKE) by geographic characteristics could identify inequities in the management of CKD that can guide policy action.

Methods

We quantified the annual incidence of MAKE in Alberta from 2003-2019, overall and by geographic characteristics of patients’ residential zip codes, using routine healthcare data available in the Alberta Kidney Disease Network (AKDN) database. CKD status for cohort eligibility was ascertained based on outpatient eGFR and defined as 2 eGFR values <60 ml/min/1.73m2 at least 60 days apart; patients entered the cohort on the date of the second qualifying eGFR measurement. MAKE was defined as all-cause death or kidney failure (i.e., chronic dialysis, transplant or sustained eGFR <15 ml/min/1.73m2) and assessed as the annual proportion of patients with the event from April 1 to March 31. Temporal trends in the rate of change of MAKE were estimated using linear regression.

Results

Among 262,392 patients (median age 75 years; 56% female), the overall incidence rate of MAKE decreased from 7.3% between 2003 and 2004 to 6.5% between 2018 and 2019; and the corresponding rate of change in the annual incidence of MAKE was -0.08 (95% confidence interval -0.10 to -0.06). There was an excess incidence rate of MAKE in rural vs urban locations between 2003 and 2004 (8.7% vs 7.4%); however, this excess rate was attenuated between 2018 and 2019 (6.7% vs 6.5%). Likewise, the excess incidence rate of MAKE in residential locations >100 km vs ≤50 km from the nearest nephrology center between 2003 and 2004 (9.3% vs 6.8%) was substantially reduced between 2018 and 2019 (6.5% vs 6.4%).

Conclusion

Disparities in incident MAKE by geographic characteristics of patients in Alberta have improved over the last 2 decades. Future studies exploring factors (e.g., CKD care indicators, population mix) that might have contributed to these noticeable improvements are needed for development of policy interventions to optimize CKD outcomes equitably for all patients.

Funding

  • Government Support – Non-U.S.